JnJ, P&G, Walgreens accused in lawsuits over cold medicine decongestant Ruchika Sharma15 Sept 2023 2:30 PM ISTJohnson & Johnson, Procter & Gamble and Walgreens are among several companies accused in lawsuits of deceiving consumers about cold...
Janssen declares positive topline results from Phase 3 study evaluating RYBREVANT given with, without lazertinib combined with chemotherapy versus chemotherapy alone Ruchika Sharma9 Sept 2023 1:45 PM ISTNew Jersey: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced positive topline results from the three-arm Phase 3 ...
Johnson & Johnson to halt hypertension drug Macitentan study Ruchika Sharma8 Sept 2023 11:43 AM ISTThe study was deemed "futile" and failed to improve exercise capacity in a broad population including inoperable patients compared to a placebo, J&J...
Janssen seeks USFDA full approval for Balversa for Urothelial Carcinoma Ruchika Sharma1 Sept 2023 12:30 PM ISTRaritan: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the submission of a supplemental New Drug Application...
CDSCO panel tells JnJ to submit clarification for weight based calculated fixed dose of Teclistamab Isra Zaman23 Aug 2023 12:54 PM ISTBased on the proposal presented by drug major Johnson & Johnson for the protocol amendment of the anticancer drug Teclistamab, the Subject Expert...
Health Bulletin 22/August/2023 Isra Zaman22 Aug 2023 4:24 PM ISTHere are the top health stories for the day:Rural, urban health training center mandatory for starting new medical college: NMC regulationsThe...
European Commission nod to reduced dosing frequency for Janssen Tecvayli Ruchika Sharma20 Aug 2023 11:30 AM ISTTeclistamab is an off-the-shelf (or ready to use) bispecific antibody.
Janssen bags USFDA nod for Akeega to treat prostate cancer Ruchika Sharma12 Aug 2023 11:35 AM ISTHorsham: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced that the U.S. Food & Drug Administration (FDA) has...
Johnson and Johnson gets USFDA accelerated nod for multiple myeloma drug Talvey Ruchika Sharma11 Aug 2023 11:29 AM ISTTALVEY is approved as a weekly or biweekly subcutaneous (SC) injection after an initial step-up phase, offering physicians the flexibility to...
Janssen seeks USFDA nod for expanded pediatric indication for HIV-1 therapy Edurant Ruchika Sharma1 Aug 2023 12:32 PM ISTTitusville: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the submission of a supplemental New Drug Application (sNDA)...
Johnson and Johnson effort to resolve talc lawsuits in bankruptcy fails second time Ruchika Sharma31 July 2023 3:30 PM ISTUS: A U.S. judge on Friday shot down Johnson & Johnson's second attempt to resolve tens of thousands of lawsuits over its talc products in...
Anuj Virmani becomes MD of JnJ MedTech India division Ruchika Sharma25 July 2023 11:41 AM ISTMumbai: Johnson & Johnson Private Limited has announced the appointment of Anuj Virmani as the Managing Director for its Johnson & Johnson...
